Dylla Scott J. 4
4 · KINETA, INC./DE · Filed Jun 25, 2025
Insider Transaction Report
Form 4
KINETA, INC./DEKANT
Dylla Scott J.
Director
Transactions
- Exercise/Conversion
Common Stock
2025-06-23$0.61/sh+12,500$7,638→ 16,500 total - Tax Payment
Common Stock
2025-06-23$0.26/sh−4,706$1,224→ 11,794 total - Award
Common Stock
2025-06-25+6,000→ 17,794 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-06-23−12,500→ 12,500 totalExercise: $0.61Exp: 2034-09-03→ Common Stock (0 underlying)
Footnotes (1)
- [F1]Pursuant to the terms of (i) the Optionholder Treatment Agreement, dated June 16, 2025, by and between Kineta, Inc. (the "Company") and the Reporting Person, and (ii) the Agreement and Plan of Merger, dated as of December 11, 2024, by and among the Company, TuHURA Biosciences, Inc., a Nevada corporation ("TuHURA"), Hura Merger Sub I, Inc., a Delaware corporation and a wholly owned subsidiary of TuHURA, Hura Merger Sub II, a Delaware limited liability company and a wholly owned subsidiary of TuHURA, and Craig Philips, as representative of the stockholders of the Company, and as amended by that certain First Amendment to Agreement and Plan of Merger, dated May 5, 2025, as approved by the Company's stockholders at the Special Meeting of Stockholders held on June 23, 2025, the options granted to the Reporting Person under the 2022 Equity Incentive Plan became fully vested on June 23, 2025.